Skip to main content
Clinical Trials/CTRI/2016/02/006587
CTRI/2016/02/006587
Completed
Phase 4

Comparative study of outcomes with adjunct use of disease modifying agents in management of knee osteoarthritis

Institute of Medical Sciences Banaras Hindu University Varanasi Uttar Pradesh India0 sites217 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Institute of Medical Sciences Banaras Hindu University Varanasi Uttar Pradesh India
Enrollment
217
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Institute of Medical Sciences Banaras Hindu University Varanasi Uttar Pradesh India

Eligibility Criteria

Inclusion Criteria

  • Inclusion Criteria:
  • The patients with radiographic evidence of suffering grade I, II and grade III Osteoarthritis.
  • The patients having mild to moderate grade of hypertension controlled with therapies as well as those with diabetes well controlled with therapies and suffering from osteoarthritis were also included.

Exclusion Criteria

  • 1\.Patients suffering from severe grades of hypertension and diabetes mellitus requiring more than oral hypoglycemic therapies were excluded.
  • 2\.Untreated or poorly controlled diabetics and hypertensives were excluded.
  • 3\.Patients suffering from any other major systemic disease or active infection were excluded.
  • 4\.Patients with H/O trauma to knee in past before or after the onset of osteoarthritic symptoms were excluded.
  • 5\.Patients with more advanced (radiological grade IV) OA were excluded.
  • 6\.Patients developing any illness causing restriction of routine for one day or more as also those needing more than 3 days course of therapy for emergent illness were excluded.
  • 7\.Occasional use of single or two doses of medications up\-to two instances during the 12 weeks observational period were allowed.
  • 8\.No case of pregnancy or H/O any surgery in last 3 years was included.
  • 9\.Patients non\-compliant to therapy at more than two recalled occasions during any 2 weeks in treatment course were excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials